M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity —— Enhancements Strengthen ...
According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and ...
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果